NCT03954548View on ClinicalTrials.gov

CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.

NACompletedINTERVENTIONAL

Enrollment

249

Participants

Timeline

Start Date

February 17, 2020

Primary Completion Date

May 7, 2021

Study Completion Date

May 7, 2021

Conditions

Colorectal Cancer

Interventions

DEVICE

CB-17-08 CADe

CB-17-08 Augmented Endoscopy System with Computer Aided Detection (CADe) function

Trial Locations (10)

17822

Geisinger Medical Center, Danville

32224

Mayo Clinic Jacksonville, Jacksonville

48236

Ascension St. John's Hospital, Detroit

54601

Mayo Clinic La Crosse, La Crosse

54703

Mayo Clinic Eau Claire, Eau Claire

64128

Kansas City VA Medical Center, Kansas City

85259

Mayo Clinic Scottsdale, Scottsdale

00153

ASL Roma 1 (Presidio Nuova regina Margherita), Roma

PO6 3LY

Queen Alexandra Hospital, Cosham

OX4 2PG

Oxford University Hospitals, Oxford

All Listed Sponsors

lead

Cosmo Artificial Intelligence-AI Ltd

INDUSTRY

NCT03954548 - CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer. | Biotech Hunter | Biotech Hunter